Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 7/20 | 0.32 |
| ▸ | CNR2 | P34972 | 7/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | MARS1 | P56192 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL677651 | 0.88 | LMNA (0.42) | LMNAGABRA2GABRB2GRM5CNR1 | |
| Butane SCHEMBL20916981 | 0.88 | LMNA (0.42) | LMNAGABRA2GABRB2GRM5CNR1 | |
| SCHEMBL471146 | 0.83 | LMNA (0.45) | LMNAGABRA2GABRB2GRM5MARS1 | |
| SCHEMBL29686790 | 0.83 | LMNA (0.45) | LMNAGABRA2GABRB2GRM5MARS1 | |
| SCHEMBL135365 | 0.83 | LMNA (0.45) | LMNAGABRA2GABRB2GRM5MARS1 | |
| Prosulfocarb SCHEMBL2372158 | 0.77 | GRM5 (0.38) | LMNAGABRA2GABRB2L3MBTL1GRM5 | |
| SCHEMBL19698080 | 0.76 | LMNA (0.41) | LMNAGABRA2GABRB2L3MBTL1GRM5 | |
| SCHEMBL6061258 | 0.75 | GABRA2 (0.42) | LMNAGABRA2GABRB2ALDH1A1SMN1; SMN2 | |
| (Rs)-Indanofan SCHEMBL14655484 | 0.75 | CHRNA1 (0.32) | — | |
| SCHEMBL29419101 | 0.75 | GABRA2 (0.42) | LMNAGABRA2GABRB2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108424-A1 | Novel complex for use in stabilizing herbicidal compositions and merthods for synthesizing and using the same | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2012-05-03 | — | — | US | claimed |
| EP-1965643-A2 | NOVEL COMPLEX FOR USE IN STABILIZING HERBICIDAL COMPOSITIONS AND METHODS FOR SYNTHESIZING AND USING THE SAME | Bayer Cropscience LP (US) | 2008-09-10 | — | — | EP | claimed |
| WO-2007067472-A2 | NOVEL COMPLEX FOR USE IN STABILIZING HERBICIDAL COMPOSITIONS AND METHODS FOR SYNTHESIZING AND USING THE SAME | BAYER CROPSCIENCE LP (US) | 2007-06-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108424-A1 | Novel complex for use in stabilizing herbicidal compositions and merthods for synthesizing and using the same | DDT, AS3MT, ACHE | LMNA 4527/4885GABRA2 2861/4885GABRB2 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.